• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Chiron Real Estate Inc. Announces First Quarter 2026 Financial Results

    5/6/26 4:05:00 PM ET
    $XRN
    Real Estate Investment Trusts
    Real Estate
    Get the next $XRN alert in real time by email

    –Announces Contracts for Three Seniors Housing Communities for an Aggregate Purchase Price of $425 Million–

    –Announces $100 Million Strategic Equity Investment from Maewyn Capital Partners–

    –Announces Reduction in Monthly Dividend to Facilitate New Strategic and Growth Plans–

    Chiron Real Estate Inc. (NYSE:XRN) (the "Company" or "Chiron"), today announced financial results for the three months ended March 31, 2026 and other data.

    Mark Decker, Jr., Chief Executive Officer and President stated, "Chiron is repositioning as a growth-oriented investor. Central to this transition is a disciplined capital allocation strategy aimed at recycling capital into investments with higher returns on invested capital. Our inaugural SHOP investments are a tremendous first step on this journey. We view today's announcement of a $100 million growth equity investment led by Maewyn Capital Partners as an endorsement of this strategy and our underlying portfolio value. While working on these transformative transactions, the Company continued to produce stable results including same property NOI growth of 3.2%. I want to commend our team for their hard work."

    In conjunction with this release, the Company has posted an updated Investor Presentation to the Investor Relations section of its website. This presentation provides additional details on Chiron's transition to a growth-oriented healthcare REIT and enhanced capital allocation strategy.

    NOTE: All share and per share data have been adjusted for all periods presented to reflect the Company's one-for-five reverse stock split that was effective September 19, 2025.

    First Quarter 2026 Highlights

    • Reported quarterly net loss attributable to common stockholders of $0.7 million, or $0.06 per diluted share, as compared to net income of $2.1 million, or $0.16 per diluted share, in the comparable prior year period.
    • Reported quarterly funds from operations attributable to common stockholders and noncontrolling interest ("FFO") of $0.97 per share and unit, as compared to $1.02 per share and unit in the comparable prior year period.
    • Reported core funds from operations attributable to common stockholders and noncontrolling interest ("Core FFO") of $1.11 per share and unit, which was unchanged compared to the comparable prior year period.
    • First quarter same-property cash net operating income ("Same-Property Cash NOI") growth was 3.2% on a year-over-year basis.
    • Quarter-end portfolio leased occupancy was 95.4%.

    Recent Events

    • On May 1, 2026, the Company signed purchase agreements (subject to customary closing conditions) for two newly constructed luxury seniors housing communities located within the affluent Potomac Yard submarket of Alexandria, Virginia for an aggregate purchase price of $249 million. The assets will be operated as a unified campus offering a full continuum of care spanning independent living, assisted living, and memory care – driving meaningful operating synergies and a superior resident experience. It is anticipated that these acquisitions will close in the second quarter. Both communities will be managed as seniors housing operating properties (SHOP) and are expected to deliver a double-digit unlevered IRR.
    • On May 6, 2026, the Company signed a purchase agreement (subject to customary closing conditions) for a newly constructed luxury senior housing community located in North Bethesda, Maryland for a purchase price of approximately $176 million. This luxury asset, located adjacent to Pike & Rose, a premier mixed-use development, offers residents a full continuum of care across a mix of independent living, assisted living, and memory care housing. It is anticipated that this acquisition will close in the fourth quarter. This community will be managed as a SHOP and is expected to deliver a double-digit unlevered IRR.
    • On May 6, 2026, the Company entered into a $100 million delayed-draw, convertible preferred equity facility with affiliates of Maewyn Capital Partners ("Maewyn"), pursuant to which Maewyn will invest up to $100 million in the Company's new 6.00% Series C Convertible Preferred Stock (subject to certain closing conditions), with an initial conversion price of $43.00 per share of common stock. In connection with this investment, Mr. Charles Fitzgerald, managing partner of Maewyn, will be appointed to our Board of Directors following the Company's 2026 annual stockholders' meeting on May 20, 2026.

    For additional information on each of these recent events, please refer to the Company's separate press releases.

    Other Events

    • Entered into a Master Note and Guaranty Agreement with affiliates of New York Life (collectively, the "Purchasers") that established an uncommitted senior unsecured note facility pursuant to which the Company may issue senior unsecured promissory notes from time to time in one or more series to the Purchasers in an aggregate principal amount of up to $150 million. As of March 31, 2026, no notes had been issued or were outstanding under the Master Note and Guaranty Agreement.
    • As of May 5, 2026, the Company's tenant at its White Rock facility in Dallas, Texas continued its Chapter 11 bankruptcy reorganization. Since the date of its bankruptcy filing through May 5, 2026, the tenant remains current in its rent obligations to us.
    • As previously announced, the Company invested $7.1 million for a 49% interest in a joint venture with a developer to facilitate the development of a 132-unit, active adult residential community in a suburb of Minneapolis, Minnesota. In connection with its establishment, the joint venture entered into a construction loan with a principal balance of $31.0 million.

    Portfolio Update

    At quarter end, the Company's portfolio was comprised of:

    • 5.1 million leasable square feet,
    • $115.3 million of annualized Cash NOI,
    • Weighted average lease term ("WALT") of 5.1 years,
    • Weighted average annual base rent escalations of 2.1%, and
    • 95.4% leased occupancy rate.

    Balance Sheet and Capital

    At March 31, 2026, consolidated debt outstanding, including borrowings on the credit facility and notes payable (both net of unamortized debt issuance costs), was $663.4 million and the Company's leverage was 44.7% of total gross assets compared to 44.4% as of December 31, 2025. As of March 31, 2026, the Company's total debt carried a weighted average interest rate of 3.6% and a weighted average remaining term of 3.9 years, with 74% fixed rate debt. The Company has no debt maturities in 2026 or 2027.

    As of May 5, 2026, the Company's borrowing capacity under the credit facility was $220.5 million.

    2026 Guidance and Common Dividends

    2026 Guidance

    As we move into an active phase of asset sales, acquisitions, and capital redeployment, we believe short-term earnings guidance becomes an increasingly poor proxy for underlying value creation. Rather than anchor investors to short-term volatility, management has elected to withdraw 2026 guidance and focus squarely on executing the portfolio transition and building long-term per-share value and earnings power. Please refer to our investor presentation to see information regarding key metrics for 2026 as well as our longer-term strategic priorities.

    Common Dividend Modification

    The Company is evolving from a yield-focused REIT into an active growth platform. Given the transformation we are resizing our dividend to focus on retaining cash flow and to accelerate the Company's acquisition strategy and accelerate the ramp of its SHOP portfolio.

    On May 5, 2026, the Board of Directors (the "Board") declared a monthly common stock cash dividend of $0.16 per share for each of July, August and September of 2026, representing quarterly cash dividends totaling $0.48 per share. Details of the dividend are contained in the table below:

    Record Date

    Payment Date

    Per Share Amount

    June 22, 2026

    July 17, 2026

    $0.16

    July 20, 2026

    August 14, 2026

    $0.16

    August 20, 2026

    September 18, 2026

    $0.16

    This compares to $0.25 per share for April, May and June 2026, and represents an approximate 36% reduction.

    Supplemental Information

    Details regarding these results can be found in the Company's supplemental financial package available on the Investor Relations section of the Company's website at http://www.chironre.com/investor/investor-overview/default.aspx.

    Conference Call and Webcast Information

    The Company will host a live webcast and conference call on Thursday, May 7, 2026 at 9:00 a.m. Eastern Time. The webcast is located on the "Investor Relations" section of the Company's website at http://www.chironre.com/investor/investor-overview/default.aspx.

    To Participate via Telephone:

    Dial in at least five minutes prior to start time and reference Chiron Real Estate Inc.

    Dial in numbers: 1-800-717-1738 or 1-646-307-1865

    Replay:

    An audio replay of the conference call will be posted on the Company's website.

    Non-GAAP Financial Measures

    General

    Management considers certain non-GAAP financial measures to be useful supplemental measures of the Company's operating performance. For the Company, non-GAAP measures consist of Funds From Operations attributable to common stockholders and noncontrolling interest ("FFO"), Core FFO (formerly Adjusted Funds From Operations), Funds Available For Distribution attributable to common stockholders and noncontrolling interest ("FAD"), Earnings Before Interest, Taxes, Depreciation and Amortization for Real Estate ("EBITDAre" and "Adjusted EBITDAre"), Net Operating Income ("NOI"), Cash NOI and Same-Property Cash NOI. A non-GAAP financial measure is generally defined as one that purports to measure financial performance, financial position or cash flows, but excludes or includes amounts that would not be so adjusted in the most comparable measure determined in accordance with GAAP. The Company reports non-GAAP financial measures because these measures are observed by management to also be among the most predominant measures used by the REIT industry and by industry analysts to evaluate REITs. For these reasons, management deems it appropriate to disclose and discuss these non-GAAP financial measures.

    The non-GAAP financial measures presented herein are not necessarily identical to those presented by other real estate companies due to the fact that not all real estate companies use the same definitions. These measures should not be considered as alternatives to net income, as indicators of the Company's financial performance, or as alternatives to cash flow from operating activities as measures of the Company's liquidity, nor are these measures necessarily indicative of sufficient cash flow to fund all of the Company's needs. Management believes that in order to facilitate a clear understanding of the Company's historical consolidated operating results, these measures should be examined in conjunction with net income and cash flows from operations as presented elsewhere herein.

    FFO and Core FFO

    FFO and Core FFO are non-GAAP financial measures within the meaning of the rules of the United States Securities and Exchange Commission ("SEC"). The Company considers FFO and Core FFO to be important supplemental measures of its operating performance and believes FFO is frequently used by securities analysts, investors, and other interested parties in the evaluation of REITs, many of which present FFO when reporting their results. In accordance with the National Association of Real Estate Investment Trusts' ("NAREIT") definition, FFO means net income or loss computed in accordance with GAAP before noncontrolling interests of holders of OP units and LTIP units, excluding gains (or losses) from sales of property and extraordinary items, property impairment losses, less preferred stock dividends, plus real estate-related depreciation and amortization (excluding amortization of debt issuance costs and the amortization of above and below market leases), and after adjustments for unconsolidated partnerships and joint ventures calculated to reflect FFO on the same basis. Because FFO excludes real estate-related depreciation and amortization (other than amortization of debt issuance costs and above and below market lease amortization expense), the Company believes that FFO provides a performance measure that, when compared period-over-period, reflects the impact to operations from trends in occupancy rates, rental rates, operating costs, development activities and interest costs, providing perspective not immediately apparent from the closest GAAP measurement, net income or loss.

    Core FFO is a non-GAAP measure used by many investors and analysts to measure a real estate company's operating performance by removing the effect of items that do not reflect ongoing property operations. Management calculates Core FFO by modifying the NAREIT computation of FFO by adjusting it for certain cash and non-cash items and certain recurring and non-recurring items. For the Company these items include: (a) recurring acquisition and disposition costs, (b) loss on the extinguishment of debt, (c) recurring straight line deferred rental revenue, (d) recurring stock-based compensation expense, (e) recurring amortization of above and below market leases, (f) recurring amortization of debt issuance costs, (g) severance and transition related expense, (h) reverse stock split expense and (i) other items related to unconsolidated partnerships and joint ventures.

    Management believes that reporting Core FFO in addition to FFO is a useful supplemental measure for the investment community to use when evaluating the operating performance of the Company on a comparative basis.

    FAD

    We calculate FAD by subtracting from Core FFO capital expenditures, including tenant improvements, and leasing commissions. Management believes FAD is useful in analyzing the portion of cash flow that is available for distribution to stockholders and unitholders. Investors, analysts and the Company utilize FAD as an indicator of common dividend potential. The FAD payout ratio, which represents annual distributions to common stockholders and unitholders expressed as a percentage of FAD, facilitates the comparison of dividend coverage between REITs.

    EBITDAre and Adjusted EBITDAre

    We calculate EBITDAre in accordance with standards established by NAREIT and define EBITDAre as net income or loss computed in accordance with GAAP plus depreciation and amortization, interest expense, gain or loss on the sale of investment properties, property impairment losses, and adjustments for unconsolidated partnerships and joint ventures to reflect EBITDAre on the same basis, as applicable.

    We define Adjusted EBITDAre as EBITDAre plus loss on extinguishment of debt, non-cash stock compensation expense, non-cash intangible amortization related to above and below market leases, severance and transition related expense, reverse stock split expense, transaction expense, adjustments related to our investments in unconsolidated joint ventures, and other normalizing items. Management considers EBITDAre and Adjusted EBITDAre important measures because they provide additional information to allow management, investors, and our current and potential creditors to evaluate and compare our core operating results and our ability to service debt.

    NOI, Cash NOI and Same-Property Cash NOI

    We consider net operating income, or NOI, to be an appropriate supplemental measure to net income because it helps both investors and management understand the core operations of our properties. We define NOI as total net (loss) income, plus depreciation and amortization expenses, general and administrative expenses, transaction expenses, impairments, gain/loss on sale of real estate, interest expense, and other non-operating items. Cash NOI and Same-Property Cash NOI are key performance indicators. Management considers these to be supplemental measures that allow investors, analysts and Company management to measure unlevered property-level cash operating results. The Company defines Cash NOI as NOI excluding non-cash items such as above and below market lease intangibles and straight-line rent. Cash NOI is historical and not necessarily indicative of future results.

    Same-Property Cash NOI compares Cash NOI for stabilized properties. Stabilized properties are properties that have been included in operations for the duration of the year-over-year comparison period presented. Accordingly, stabilized properties exclude properties that were recently acquired or disposed of, properties classified as held for sale, properties undergoing redevelopment, and newly redeveloped or developed properties. Same-Property Cash NOI also excludes lease terminations fees and joint venture and other income in order to remove non-recurring items and joint venture-related income from our NOI.

    Forward-Looking Statements

    Certain statements contained herein may be considered "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, and it is the Company's intent that any such statements be protected by the safe harbor created thereby. These forward-looking statements are identified by their use of terms and phrases such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "should," "plan," "predict," "project," "will," "continue" and other similar terms and phrases, including references to assumptions and forecasts of future results. Except for historical information, the statements set forth herein including, but not limited to, any statements regarding our earnings, our liquidity, our tenants' ability to pay rent to us, expected financial performance (including future cash flows associated with our joint venture or new tenants or the expansion of current properties), 2026 Core FFO guidance, future dividends, interest rates or other financial items; any other statements concerning our plans, strategies, objectives and expectations for future operations and future portfolio occupancy rates, our pipeline of acquisition opportunities and expected acquisition activity, including the timing and/or successful completion of any acquisitions and expected rent receipts on these properties, our expected disposition activity, including the timing and/or successful completion of any dispositions and the expected use of proceeds therefrom, and any statements regarding future economic conditions or performance are forward-looking statements. These forward-looking statements are based on our current expectations, estimates and assumptions and are subject to certain risks and uncertainties. Although the Company believes that the expectations, estimates and assumptions reflected in its forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of the Company's forward-looking statements. Additional information concerning us and our business, including additional factors that could materially and adversely affect our financial results, include, without limitation, the risks described under Part I, Item 1A - Risk Factors, in our Annual Report on Form 10-K, our Quarterly Reports on Form 10-Q, and in our other filings with the SEC. You are cautioned not to place undue reliance on forward-looking statements. The Company does not intend, and undertakes no obligation, to update any forward-looking statement.

    About Chiron

    Chiron is a real estate investment trust ("REIT") focused on investing in the future of healthcare. At Chiron we strive to deliver value at the intersection of care, capital and real estate. Additional information about Chiron can be obtained on its website at www.chironre.com.

     
     
     

    CHIRON REAL ESTATE INC.

    Condensed Consolidated Balance Sheets

    (Unaudited, and in thousands, except par values) 

     

     

     

    As of

     

     

    March 31,

    2026

     

    December 31,

    2025

    Assets

     

     

     

     

     

     

    Investment in real estate:

     

     

     

     

     

     

    Land

     

    $

    169,917

     

     

    $

    169,917

     

    Building

     

     

    1,073,953

     

     

     

    1,072,124

     

    Site improvements

     

     

    25,783

     

     

     

    25,741

     

    Tenant improvements

     

     

    81,168

     

     

     

    80,397

     

    Acquired lease intangible assets

     

     

    144,573

     

     

     

    144,573

     

     

     

     

    1,495,394

     

     

     

    1,492,752

     

    Less: accumulated depreciation and amortization

     

     

    (353,309

    )

     

     

    (338,096

    )

    Investment in real estate, net

     

     

    1,142,085

     

     

     

    1,154,656

     

    Cash and cash equivalents

     

     

    8,183

     

     

     

    9,084

     

    Restricted cash

     

     

    2,778

     

     

     

    2,805

     

    Tenant receivables, net

     

     

    6,800

     

     

     

    7,225

     

    Due from related parties

     

     

    177

     

     

     

    162

     

    Escrow deposits

     

     

    546

     

     

     

    556

     

    Deferred assets

     

     

    29,953

     

     

     

    28,907

     

    Derivative assets

     

     

    7,218

     

     

     

    6,102

     

    Goodwill

     

     

    5,903

     

     

     

    5,903

     

    Investment in unconsolidated joint ventures

     

     

    8,902

     

     

     

    1,781

     

    Other assets

     

     

    25,474

     

     

     

    25,284

     

    Total assets

     

    $

    1,238,019

     

     

    $

    1,242,465

     

     

     

     

     

     

     

     

    Liabilities and Equity

     

     

     

     

     

     

    Liabilities:

     

     

     

     

     

     

    Credit Facility, net of unamortized debt issuance costs of $9,686 and $10,476 at March 31, 2026 and December 31, 2025, respectively

     

    $

    662,314

     

     

    $

    652,699

     

    Notes payable, net of unamortized debt issuance costs of $0 at March 31, 2026 and December 31, 2025

     

     

    1,096

     

     

     

    1,153

     

    Accounts payable and accrued expenses

     

     

    15,022

     

     

     

    18,289

     

    Dividends payable

     

     

    12,708

     

     

     

    12,484

     

    Security deposits

     

     

    3,486

     

     

     

    3,421

     

    Other liabilities

     

     

    18,368

     

     

     

    19,410

     

    Acquired lease intangible liability, net

     

     

    4,375

     

     

     

    4,944

     

    Total liabilities

     

     

    717,369

     

     

     

    712,400

     

    Commitments and Contingencies

     

     

     

     

     

     

    Equity:

     

     

     

     

     

     

    Preferred stock, $0.001 par value, 10,000 shares authorized; 5,155 shares issued and outstanding at March 31, 2026 and December 31, 2025 (liquidation preference of $128,875 at March 31, 2026 and December 31, 2025)

     

     

    124,106

     

     

     

    124,106

     

    Common stock, $0.001 par value, 100,000 shares authorized; 13,235 shares issued and outstanding at March 31, 2026 and December 31, 2025

     

     

    13

     

     

     

    13

     

    Additional paid-in capital

     

     

    729,514

     

     

     

    729,514

     

    Accumulated deficit

     

     

    (360,640

    )

     

     

    (349,965

    )

    Accumulated other comprehensive income

     

     

    7,218

     

     

     

    6,102

     

    Total Chiron Real Estate Inc. stockholders' equity

     

     

    500,211

     

     

     

    509,770

     

    Noncontrolling interest

     

     

    20,439

     

     

     

    20,295

     

    Total equity

     

     

    520,650

     

     

     

    530,065

     

    Total liabilities and equity

     

    $

    1,238,019

     

     

    $

    1,242,465

     

       
       
       
       

    CHIRON REAL ESTATE INC.

    Condensed Consolidated Statements of Operations

    (Unaudited, and in thousands, except per share amounts)

       

    Three Months Ended

    March 31,

    2026

     

    2025

    Revenue

     

     

     

     

     

     

     

    Rental revenue

     

     $

     38,021

     

     

    $

     34,595

     

    Other income

     

     

            43

     

     

     

     23

     

    Total revenue

     

     

     38,064

     

     

     

     34,618

     

     

     

     

     

     

     

     

     

    Expenses

     

     

     

     

     

     

     

    General and administrative

     

     

     5,089

     

     

     

     3,620

     

    Operating expenses

     

     

     9,250

     

     

     

     7,585

     

    Depreciation expense

     

     

     11,087

     

     

     

     10,307

     

    Amortization expense

     

     

     3,740

     

     

     

     3,520

     

    Interest expense

     

     

     7,233

     

     

     

     7,167

     

    Total expenses

     

     

     36,399

     

     

     

     32,199

     

     

     

     

     

     

     

     

     

    Income before other income (expense)

     

     

     1,665

     

     

     

     2,419

     

    Gain on sale of investment properties

     

     

    ―

     

     

     

     1,358

     

    Equity loss from unconsolidated joint ventures

     

     

     (11

    )

     

     

     (40

    )

     

     

     

     

     

     

     

     

    Net income

     

     $

     1,654

     

     

    $

     3,737

     

    Less: Preferred stock dividends

     

     

     (2,473

    )

     

     

     (1,455

    )

    Less: Net loss (income) attributable to noncontrolling interest

     

     

     70

     

     

     

     (178

    )

    Net (loss) income attributable to common stockholders

     

    $

     (749

    )

     

    $

     2,104

     

     

     

     

     

     

     

     

     

    Net (loss) income attributable to common stockholders per share – basic and diluted

     

    $

     (0.06

    )

     

    $

     0.16

     

     

     

     

     

     

     

     

     

    Weighted average common shares outstanding – basic and diluted

     

     

     13,235

     

     

     

     13,374

     
     
     
     

    Chiron Real Estate Inc.

    Reconciliation of Net Income to FFO, Core FFO and FAD

    (Unaudited, and in thousands, except per share and unit amounts) 

     

     

     

    Three Months Ended

    March 31, 

     

     

    2026

      

    2025

     

     

     

    Net income

     

    $

    1,654

     

     

    $

     3,737

     

    Less: Preferred stock dividends

     

     

     (2,473

    )

     

     

     (1,455

    )

    Depreciation and amortization expense

     

     

     14,802

     

     

     

     13,806

     

    Depreciation and amortization expense from unconsolidated joint ventures

     

     

    73

     

     

     

    49

     

    Gain on sale of investment properties

     

     

    —

     

     

     

    (1,358

    )

    FFO attributable to common stockholders and noncontrolling interest

     

    $

     14,056

     

     

    $

     14,779

     

    Amortization of above market leases, net

     

     

     146

     

     

     

     452

     

    Straight line deferred rental revenue

     

     

     (204

    )

     

     

     (57

    )

    Stock-based compensation expense

     

     

     1,229

     

     

     

     151

     

    Amortization of debt issuance costs and other

     

     

     807

     

     

     

     559

     

    Severance and transition related expense

     

     

    —

     

     

     

     104

     

    Other adjustments from unconsolidated joint ventures

     

     

    (19

    )

     

     

     31

     

    Core FFO attributable to common stockholders and noncontrolling interest

     

    $

     16,015

     

     

    $

     16,019

     

     

     

     

     

     

     

     

    Net (loss) income attributable to common stockholders per share – basic and diluted

     

    $

     (0.06

    )

     

    $

     0.16

     

    FFO attributable to common stockholders and noncontrolling interest per share and unit

     

    $

     0.97

     

     

    $

     1.02

     

    Core FFO attributable to common stockholders and noncontrolling interest per share and unit

     

    $

     1.11

     

     

    $

     1.11

     

     

     

     

     

     

     

     

    Weighted Average Shares and Units Outstanding – basic and diluted

     

     

     14,429

     

     

     

     14,475

     

     

     

     

     

     

     

     

    Weighted Average Shares and Units Outstanding:

     

     

     

     

     

     

    Weighted Average Common Shares

     

     

     13,235

     

     

     

     13,375

     

    Weighted Average OP Units

     

     

     444

     

     

     

     449

     

    Weighted Average LTIP Units

     

     

     750

     

     

     

     651

     

    Weighted Average Shares and Units Outstanding – basic and diluted

     

     

     14,429

     

     

     

     14,475

     

     

    Core FFO attributable to common stockholders and noncontrolling interest

    $

    16,015

     

    $

    16,019

     

    Tenant improvements

    (594

    )

    (704

    )

    Leasing commissions

    (550

    )

    (115

    )

    Building capital

    (1,550

    )

    (1,907

    )

    FAD attributable to common stockholders and noncontrolling interest

    $

    13,321

     

    $

    13,293

     

     
     
     
     

    Chiron Real Estate Inc.

    Reconciliation of Net Income to EBITDAre and Adjusted EBITDAre

    (Unaudited, and in thousands) 

     

     

    Three Months Ended

    March 31,

     

    2026

     

    2025

     

    Net income

    $

    1,654

     

     

    $

    3,737

     

    Interest expense

     

    7,233

     

     

     

    7,167

     

    Depreciation and amortization expense

     

    14,827

     

     

     

    13,827

     

    Unconsolidated joint ventures EBITDAre adjustments (1)

     

    111

     

     

     

    85

     

    Gain on sale of investment properties

     

    —

     

     

     

    (1,358

    ) 

    EBITDAre

    $

    23,825

     

     

    $

    23,458

     

    Stock-based compensation expense

     

    1,229

     

     

     

    151

     

    Amortization of above market leases, net

     

    146

     

     

     

    452

     

    Severance and transition related expense

     

    —

     

     

     

    104

     

    Interest rate swap mark-to-market at unconsolidated joint ventures

     

    (19

    )

     

     

    35

     

    Adjusted EBITDAre

    $

    25,181

     

     

    $

    24,200

     

    _____________________________

    (1)

    Includes joint venture interest, depreciation and amortization, and gain on sale of investment properties, if applicable, included in joint venture net income or loss.

       
       
       
       

    Chiron Real Estate Inc.

    Reconciliation of Net Income to NOI, Cash NOI and Same-Property Cash NOI

    (Unaudited, and in thousands)

       

    Three Months Ended

    March 31,

     

     2026

        

     2025

       

    Net income

    $

     1,654

     

     

    $

     3,737

     

    General and administrative expense

     

    5,089

     

     

     

    3,620

     

    Depreciation and amortization expense

     

     14,827

     

     

     

     13,827

     

    Interest expense

     

     7,233

     

     

     

     7,167

     

    Gain on sale of investment properties

     

     ―

     

     

     

     (1,358

    )

    Proportionate Share of Unconsol. JV Adj.

     

    92

     

     

     

    120

     

    NOI

    $

     28,895

     

     

    $

     27,113

     

    Amortization of above market leases, net

     

     146

     

     

     

     452

     

    Straight line deferred rental revenue

     

    (204

    )

     

     

    (57

    )

    Proportionate Share of Unconsol. JV Adj.

     

    (2

    )

     

     

    (5

    )

    Cash NOI

    $

     28,835

     

     

    $

     27,503

     

    Assets not held for all periods

     

    (1,313

    )

     

     

    (848

    )

    Joint venture and other income

     

    (122

    )

     

     

    (98

    )

    Same-property cash NOI

    $

    27,400

     

     

    $

    26,557

     

       
       

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20260506552982/en/

    Investor Relations

    Email: Investors@chironre.com

    Phone: 202-524-6869

    Get the next $XRN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $XRN

    DatePrice TargetRatingAnalyst
    5/7/2026$38.00Buy → Neutral
    Compass Point
    More analyst ratings

    $XRN
    SEC Filings

    View All

    Chiron Real Estate Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

    8-K - Chiron Real Estate Inc. (0001533615) (Filer)

    6/2/26 4:30:45 PM ET
    $XRN
    Real Estate Investment Trusts
    Real Estate

    Chiron Real Estate Inc. filed SEC Form 8-K: Leadership Update, Entry into a Material Definitive Agreement, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Chiron Real Estate Inc. (0001533615) (Filer)

    5/20/26 5:24:13 PM ET
    $XRN
    Real Estate Investment Trusts
    Real Estate

    Chiron Real Estate Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

    8-K - Chiron Real Estate Inc. (0001533615) (Filer)

    5/8/26 4:30:25 PM ET
    $XRN
    Real Estate Investment Trusts
    Real Estate

    $XRN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Chiron Real Estate downgraded by Compass Point with a new price target

    Compass Point downgraded Chiron Real Estate from Buy to Neutral and set a new price target of $38.00

    5/7/26 8:01:57 AM ET
    $XRN
    Real Estate Investment Trusts
    Real Estate

    $XRN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Chiron Real Estate Inc. Completes Acquisition of Inaugural SHOP Communities

    –Inaugural Senior Housing Investments Position Company for Growth– Chiron Real Estate Inc. (NYSE:XRN) (the "Company" or "Chiron"), announced today that it has completed the previously announced acquisition of The Landing (the "Landing") and The Riviera (the "Riviera"), two premier senior living communities located in the Washington, DC MSA, from affiliates of Silverstone Senior Living ("Silverstone") for an aggregate purchase price of $249 million. "Crossing the finish line on this transaction represents a significant milestone for Chiron as we successfully enter the senior housing space," said Mark Decker, Jr., Chief Executive Officer of Chiron Real Estate Inc. "The Landing and Riviera

    6/1/26 5:00:00 PM ET
    $XRN
    Real Estate Investment Trusts
    Real Estate

    Aditxt, Inc. Appoints Jeffrey M. Busch as Interim Chief Executive Officer; Founder and Former CEO of $1B NYSE Enterprise Which Delivered ~8.5% Dividends to Shareholders

    Seasoned executive who founded and built an NYSE-listed healthcare real estate company to over $1 billion in enterprise value — delivering an average dividend yield of approximately 8.5% to shareholders — brings capital markets depth, healthcare sector expertise, and commercial discipline to lead Aditxt's next chapter of revenue-driven growth. Aditxt, Inc. (NASDAQ:ADTX)("Aditxt" or the "Company"), a life sciences platform company accelerating promising health innovations, today announced the appointment of Jeffrey M. Busch as Interim Chief Executive Officer of Aditxt, Inc., effective May 31, 2026. Mr. Busch, who has served as Chief Executive Officer of Aditxt's CLIA-certified precision on

    6/1/26 8:15:00 AM ET
    $ADTX
    $GMRE
    $XRN
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Real Estate Investment Trusts
    Real Estate

    Chiron Real Estate Inc. Announces Appointment of Charles Fitzgerald to its Board of Directors and the Declaration of its Second Quarter Preferred Dividends

    Chiron Real Estate Inc. (NYSE:XRN) (the "Company" or "Chiron"), today announced the appointment of Charles Fitzgerald to the Company's Board of Directors (the "Board"), effective as of May 20, 2026, and the declaration of the Company's second quarter 2026 preferred dividends. Mr. Fitzgerald will serve as a member of the Board's Compensation and Nominating and Corporate Governance Committees. Underscoring his strong alignment with shareholder interests, Mr. Fitzgerald holds 97,293 shares of Chiron common stock via affiliated entities, representing approximately $3.4 million of invested capital. Appointment of Charles Fitzgerald to the Board Mr. Fitzgerald, age 51, is the Founder and Ma

    5/20/26 4:05:00 PM ET
    $XRN
    Real Estate Investment Trusts
    Real Estate

    $XRN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Fitzgerald Charles

    4 - Chiron Real Estate Inc. (0001533615) (Issuer)

    6/2/26 5:46:06 PM ET
    $XRN
    Real Estate Investment Trusts
    Real Estate

    SEC Form 4 filed by Director Wittman Lori

    4 - Chiron Real Estate Inc. (0001533615) (Issuer)

    5/21/26 5:42:02 PM ET
    $XRN
    Real Estate Investment Trusts
    Real Estate

    SEC Form 4 filed by Director Fitzgerald Charles

    4 - Chiron Real Estate Inc. (0001533615) (Issuer)

    5/21/26 5:40:47 PM ET
    $XRN
    Real Estate Investment Trusts
    Real Estate

    $XRN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Cypher Matthew bought $49,874 worth of shares (1,420 units at $35.12), increasing direct ownership by 526% to 1,690 units (SEC Form 4)

    4 - Chiron Real Estate Inc. (0001533615) (Issuer)

    5/15/26 5:00:23 PM ET
    $XRN
    Real Estate Investment Trusts
    Real Estate

    Director Wittman Lori bought $99,515 worth of shares (2,940 units at $33.85) (SEC Form 4)

    4 - Chiron Real Estate Inc. (0001533615) (Issuer)

    5/13/26 7:05:32 PM ET
    $XRN
    Real Estate Investment Trusts
    Real Estate

    Director Marston Ronald bought $51,110 worth of shares (1,500 units at $34.07) (SEC Form 4)

    4 - Chiron Real Estate Inc. (0001533615) (Issuer)

    5/13/26 7:03:36 PM ET
    $XRN
    Real Estate Investment Trusts
    Real Estate

    $XRN
    Financials

    Live finance-specific insights

    View All

    Chiron Real Estate Inc. Announces $100 Million Strategic Convertible Perpetual Preferred Equity Investment Led by Maewyn Capital Partners

    Chiron Real Estate Inc. (NYSE:XRN) (the "Company" or "Chiron"), today announced the entry into an agreement providing for up to a $100 million delayed-draw convertible perpetual preferred equity investment led by Maewyn Capital Partners ("Maewyn"). "This growth equity investment represents an important milestone in the repositioning of Chiron. Maewyn's capital provides long-term flexibility and is expected to accelerate our transition toward higher-return opportunities across the healthcare real estate spectrum. We are focused on disciplined capital allocation and believe this investment further aligns our capital structure with our objective of driving long-term earnings growth," said Ma

    5/6/26 4:06:00 PM ET
    $XRN
    Real Estate Investment Trusts
    Real Estate

    Chiron Real Estate Inc. Announces First Quarter 2026 Financial Results

    –Announces Contracts for Three Seniors Housing Communities for an Aggregate Purchase Price of $425 Million– –Announces $100 Million Strategic Equity Investment from Maewyn Capital Partners– –Announces Reduction in Monthly Dividend to Facilitate New Strategic and Growth Plans– Chiron Real Estate Inc. (NYSE:XRN) (the "Company" or "Chiron"), today announced financial results for the three months ended March 31, 2026 and other data. Mark Decker, Jr., Chief Executive Officer and President stated, "Chiron is repositioning as a growth-oriented investor. Central to this transition is a disciplined capital allocation strategy aimed at recycling capital into investments with higher returns on

    5/6/26 4:05:00 PM ET
    $XRN
    Real Estate Investment Trusts
    Real Estate

    Chiron Real Estate Inc. Announces Dates for 2026 First Quarter Earnings Release and Webcast

    Chiron Real Estate Inc. (NYSE:XRN) (the "Company"), announced today that it intends to release its first quarter 2026 financial results after the market closes on Wednesday, May 6, 2026. The Company intends to hold a conference call to discuss those results the following day, Thursday, May 7, 2026, at 9:00 a.m. Eastern Time. The conference call will be hosted by President and Chief Executive Officer Mark Decker, Jr., Chief Financial Officer Robert Kiernan, Chief Investment Officer Alfonzo Leon and Chief Operating Officer Danica Holley. Webcast Information Participants may access the call via live webcast by visiting the "Investor Relations" section of the Company's new website at www.ch

    4/16/26 8:00:00 AM ET
    $XRN
    Real Estate Investment Trusts
    Real Estate

    $XRN
    Leadership Updates

    Live Leadership Updates

    View All

    Aditxt, Inc. Appoints Jeffrey M. Busch as Interim Chief Executive Officer; Founder and Former CEO of $1B NYSE Enterprise Which Delivered ~8.5% Dividends to Shareholders

    Seasoned executive who founded and built an NYSE-listed healthcare real estate company to over $1 billion in enterprise value — delivering an average dividend yield of approximately 8.5% to shareholders — brings capital markets depth, healthcare sector expertise, and commercial discipline to lead Aditxt's next chapter of revenue-driven growth. Aditxt, Inc. (NASDAQ:ADTX)("Aditxt" or the "Company"), a life sciences platform company accelerating promising health innovations, today announced the appointment of Jeffrey M. Busch as Interim Chief Executive Officer of Aditxt, Inc., effective May 31, 2026. Mr. Busch, who has served as Chief Executive Officer of Aditxt's CLIA-certified precision on

    6/1/26 8:15:00 AM ET
    $ADTX
    $GMRE
    $XRN
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Real Estate Investment Trusts
    Real Estate

    Chiron Real Estate Inc. Announces Appointment of Charles Fitzgerald to its Board of Directors and the Declaration of its Second Quarter Preferred Dividends

    Chiron Real Estate Inc. (NYSE:XRN) (the "Company" or "Chiron"), today announced the appointment of Charles Fitzgerald to the Company's Board of Directors (the "Board"), effective as of May 20, 2026, and the declaration of the Company's second quarter 2026 preferred dividends. Mr. Fitzgerald will serve as a member of the Board's Compensation and Nominating and Corporate Governance Committees. Underscoring his strong alignment with shareholder interests, Mr. Fitzgerald holds 97,293 shares of Chiron common stock via affiliated entities, representing approximately $3.4 million of invested capital. Appointment of Charles Fitzgerald to the Board Mr. Fitzgerald, age 51, is the Founder and Ma

    5/20/26 4:05:00 PM ET
    $XRN
    Real Estate Investment Trusts
    Real Estate

    Aditxt Subsidiary Ignite Proteomics Appoints Public Company Veteran Jeff Busch as Chief Executive Officer

    Busch brings public company leadership and capital markets experience to support Ignite's next phase of growth Aditxt, Inc. (NASDAQ:ADTX) ("Aditxt" or the "Company"), a social innovation platform accelerating promising health innovations, today announced the appointment of Jeff Busch as Chief Executive Officer of its subsidiary, Ignite Proteomics, LLC ("Ignite" or "Ignite Proteomics"). Ignite Proteomics was recently acquired by Aditxt and operates a commercial-stage precision oncology platform designed to guide cancer therapy selection through functional protein profiling. The platform measures active proteins inside tumors to help oncologists determine which targeted therapies are most

    3/19/26 8:15:00 AM ET
    $ADTX
    $GMRE
    $XRN
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Real Estate Investment Trusts
    Real Estate